
Epsilogen
Operator of an immuno-oncology company intended to develop immunoglobulin antibodies for the treatment of cancer. The company's offerings include IgE-based drugs that have greater potency, enhanced tu...
Valuation
$0
Share Price
N/A
Total Raised
$66.7M
Last Round
N/A